Findlay Park Partners LLP Purchases New Position in Agilent Technologies, Inc. $A

Findlay Park Partners LLP acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,312,063 shares of the medical research company’s stock, valued at approximately $174,281,000. Agilent Technologies comprises about 2.4% of Findlay Park Partners LLP’s portfolio, making the stock its 19th biggest holding. Findlay Park Partners LLP owned about 0.46% of Agilent Technologies as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Norges Bank bought a new position in shares of Agilent Technologies during the fourth quarter worth $549,158,000. Bank of New York Mellon Corp increased its position in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after buying an additional 2,440,360 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after buying an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after buying an additional 1,340,161 shares during the period. Finally, William Blair Investment Management LLC acquired a new stake in Agilent Technologies during the 2nd quarter worth $170,987,000.

Agilent Technologies Trading Up 1.9%

NYSE A opened at $159.25 on Friday. The stock has a market capitalization of $44.98 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 2.81 and a beta of 1.25. The stock’s 50 day moving average price is $137.57 and its two-hundred day moving average price is $126.23. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.51.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same period last year, the business earned $1.31 EPS. The business’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts anticipate that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on A shares. Piper Sandler initiated coverage on Agilent Technologies in a research note on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price for the company. TD Cowen raised their price target on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company decreased their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.